reference/6057177

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6057177

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	1494
issn	1528-0020 0006-4971
issueIdentifier	14
pageRange	1486-1494
publicationName	Blood
startingPage	1486
bibliographicCitation	Morschhauser F, Salles G, Le Gouill S, Tilly H, Thieblemont C, Bouabdallah K, Fabiani B, Ménard C, Tarte K, Cartron G, Houot R. An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma. Blood. 2018 Oct 04;132(14):1486–94. PMID: 30068505; PMCID: PMC6225348.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9840-2128 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6809-917X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55bb414ee14a3587ab5bcd6a85792238 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81bf200892217b68b3a6b06068ba9922 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43437dc6a25bb3a52c2ba1ccde9ad81b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9541-8666 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8f78cf6d019c940b48aa5f39434ce70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e3965dc0e7b6972c17a2c16d2e9a2c8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a4964432b561515ff90e4b782ad1c72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b118bf224c1296ff66b8093b66777a76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c81783443b00c9e92e03af005306ea28 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3714-9824 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf4f1c9ce9777c377b8cbfc26055ebe9
date	2018-10-04^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6225348 https://doi.org/10.1182/blood-2018-05-853499 https://pubmed.ncbi.nlm.nih.gov/30068505
isPartOf	https://portal.issn.org/resource/ISSN/0006-4971 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243 https://portal.issn.org/resource/ISSN/1528-0020
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma
discusses	http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M000626416 http://id.nlm.nih.gov/mesh/M0479831 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0582537
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016393Q000188 http://id.nlm.nih.gov/mesh/D020533Q000627 http://id.nlm.nih.gov/mesh/D000077269Q000627 http://id.nlm.nih.gov/mesh/D061067Q000627 http://id.nlm.nih.gov/mesh/D000074322Q000627 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D008224Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D020533Q000009 http://id.nlm.nih.gov/mesh/D000077269Q000008 http://id.nlm.nih.gov/mesh/D020533Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000074322Q000008 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D000074322Q000009 http://id.nlm.nih.gov/mesh/D061067Q000008 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D061067Q000009 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000077269Q000009 http://id.nlm.nih.gov/mesh/D000971Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9856 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8389 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_42cfbcd47747eec326f49bd492e9a41a http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7333 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d180f13a3f81bf5e3d1904187dad811f http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71464628

Showing number of triples: 1 to 76 of 76.